{"id":116538,"date":"2010-12-17T00:00:00","date_gmt":"2010-12-17T00:00:00","guid":{"rendered":"http:\/\/clarivate.com\/report\/hpdaprtxfa10-marketaccess-texas-fall-2010-health-plan-analysis\/"},"modified":"2010-12-17T00:00:00","modified_gmt":"2010-12-17T00:00:00","slug":"hpdaprtxfa10-marketaccess-texas-fall-2010-health-plan-analysis","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/hpdaprtxfa10-marketaccess-texas-fall-2010-health-plan-analysis\/","title":{"rendered":"Texas | Fall | 2010 | Health Plan Analysis"},"content":{"rendered":"<p>Texas employers are making only minor benefit changes to retain grandfathered status, including small increases to drug copays. The next state budget includes a major expansion of managed Medicaid and would carve in the drug benefit, giving MCOs more control over drug benefit administration. HealthSpring&#039;s planned purchase of Bravo Health could shake up the Medicare market by giving the insurer entrance to El Paso and San Antonio.<\/p>\n","protected":false},"template":"","class_list":["post-116538","report","type-report","status-publish","hentry","report-gateway-marketaccess","marketaccess-product-health-plan-data-analysis","marketaccess-state-texas","marketaccess-date-566"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/116538","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":0,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/116538\/revisions"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=116538"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}